LZ’s three‑month outperformance (‑13.9% vs ‑23.5% for the S&P) is the most notable finding, as it demonstrates that the stock has decoupled from the worst of market sentiment, hinting at underlying fundamentals—such as recurring subscription revenue—that may cushion further declines.
The persistent negative annualized returns (‑20.9% over 3Y and ‑31.8% full history) quantify a long‑term capital erosion risk; if LZ fails to accelerate subscription growth or improve cost efficiency, the stock could continue lagging the market, eroding investor equity at an estimated rate of ~2–3% per year beyond current trajectories.
The concentration risk is pronounced: a 5% divestiture by institutions would represent roughly 4.6% of total shares outstanding, potentially triggering a rapid sell‑off and widening the already large -51% drawdown window.
The 10.9% YoY revenue surge—well above the historical 6.8% CAGR—signals that LegalZoom’s recent product mix shift toward higher‑margin subscription services is gaining traction, positioning the company for accelerated top‑line growth and improved earnings visibility.
The narrow 1.9% operating margin leaves little cushion for cost overruns; a 0.5 percentage‑point increase in SG&A would cut net income by roughly $3.8 M (≈20% of EPS), highlighting the risk that heightened competition or increased marketing spend could erode profitability.
The most striking profitability signal is the 10.3‑point swing in ROE, driven by a 30% reduction in financial leverage; this indicates that LegalZoom can now deliver shareholder returns without relying on excessive borrowing, a positive shift for risk‑adjusted investors.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 9.0 | 2.0 | 1.42 | 3.09 | 9.5 | 6.8 | 2.9 |
| 2024 | 32.1 | 4.4 | 1.82 | 4.01 | 55.1 | 32.9 | 8.0 |
| 2023 | 8.3 | 2.1 | 1.48 | 2.65 | 14.5 | 11.5 | 3.1 |
| 2022 | -34.2 | -7.9 | 1.53 | 2.85 | -35.8 | -26.7 | -12.0 |
| 2021 | -55.0 | -18.9 | 1.33 | 2.18 | -53.0 | -42.1 | -25.2 |
| 2020 | -1.8 | 2.1 | 1.87 | -0.46 | 93.9 | 3.9 | |
| 2019 | -1.3 | 1.8 | 2.04 | -0.36 | 153.1 | 3.7 |
The decreasing asset turnover (down 30%) could signal underutilized assets; if revenue growth stalls, the firm may face diminishing ROIC margins and reduced ability to offset fixed cost structures.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 256 | 0 | 12 | 34 | 38 | -27 |
| 2024 | 200 | 0 | 7 | 36 | 47 | -41 |
| 2023 | 247 | 0 | 7 | 31 | 49 | -43 |
| 2022 | 239 | 0 | 8 | 25 | 44 | -36 |
| 2021 | 274 | 26 | 7 | 30 | 61 | -28 |
| 2020 | 195 | 0 | 7 | 40 | 68 | -61 |
| 2019 | 179 | 0 | 9 | 54 | 45 | -36 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $531M | $359M | $172M | $24M | $-179M | $203M | $240M | $319M |
| 2024 | $374M | $281M | $93M | $8M | $-134M | $142M | $191M | $266M |
| 2023 | $448M | $279M | $169M | $9M | $-217M | $226M | $275M | $264M |
| 2022 | $405M | $263M | $142M | $11M | $-178M | $189M | $242M | $249M |
| 2021 | $431M | $233M | $198M | $-239M | $239M | $267M | $229M | |
| 2020 | $252M | $803M | $-551M | $515M | $401M | $114M | $134M | $200M |
| 2019 | $200M | $757M | $-557M | $518M | $469M | $49M | $69M | $159M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $178M | $-40M | $-77M | $-30M | $148M | $-81M | |
| 2024 | $136M | $-36M | $-183M | $-36M | $100M | $-165M | |
| 2023 | $124M | $-32M | $-56M | $-32M | $93M | $-55M | |
| 2022 | $74M | $-31M | $-93M | $-22M | $52M | $-95M | |
| 2021 | $54M | $-78M | $123M | $-12M | $42M | $-0M | |
| 2020 | $93M | $-13M | $-15M | $-11M | $82M | $-8M | $-0M |
| 2019 | $53M | $-21M | $-13M | $-18M | $34M | $-6M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net